Safety and outcomes of advanced IBD therapies in patients with HIV: a propensity-matched cohort analysis
In this large multicenter cohort, AT use in HIV-IBD was rare but not associated with higher risks of infection, cancer, surgery, or death. These findings support the safety of AT in this population.
Authors
- Avleen Kaur
- I Goren
- Avneet Kaur
Institutions
- SUNY Upstate Medical University (US)
Publication Details
- Journal
- Inflammatory Bowel Diseases
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1093/ibd/izag015
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 30.93